MARATTO

article · Naunyn-Schmiedeberg s Archives of Pharmacology

Telmisartan attenuates N-nitrosodiethylamine-induced hepatocellular carcinoma in mice by modulating the NF-κB-TAK1-ERK1/2 axis in the context of PPARγ agonistic activity

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Peroxisome Proliferator-Activated Receptors
  • Cancer, Lipids, and Metabolism
  • Drug Transport and Resistance Mechanisms

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1007/s00210-019-01706-2

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.